Search

Search Constraints

You searched for: Author/Creator Suehiro, Satoshi

Search Results

1. ACTR-04. BIOMARK: A PHASE II STUDY OF BEVACIZUMAB BEYOND PROGRESSION FOR NEWLY DIAGNOSED GLIOBLASTOMA: SAFETY, EFFICACY AND PROSPECTIVE BIOMARKER ANALYSIS. (11th November 2019)

2. ANGI-2 Identification and functions of CD44 as a predictor for bevacizumab-resistant glioblastoma to optimally treat the tumor with bevacizumab. (6th December 2021)

6. CBMS-04 SIGNIFICANT ROLE OF HYPOXIA IN THE EXPRESSION AND FUNCTION OF OSTEOPONTIN IN CD44-HIGHLY EXPRESSED GLIOMA STEM-LIKE CELLS IN TUMOR PROGRESSION OF GLIOBLASTOMA. (16th December 2019)

7. CD44 expression in the tumor periphery predicts the responsiveness to bevacizumab in the treatment of recurrent glioblastoma. (5th February 2021)

8. Clinical utility of new bone imaging using zero-echo-time sequence in neurosurgical procedures: Can zero-echo-time be used in clinical practice in neurosurgery?. Issue 3 (June 2023)

9. Comparison of the Signal Intensity of Vestibular Schwannoma Between Growing and Nongrowing Tumors. (20th August 2021)

10. COT-3 Exosomal microRNA expression signature in blood and cerebrospinal fluid of glioblastoma patients. (6th December 2021)